Cohen Neil Harris's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed Sep 1, 2026
- Accession no.
- 0001178913-26-004371
- Filed
- Sep 1, 2026, 10:05 AM ET
- Trade date
- Jul 16, 2020-Aug 28, 2026
- Filing delay
- 2,238 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 7 derivative transactions. Open-market sales total $6.52K. It was filed 2238 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cohen Neil HarrisCIK 0001840006 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | American Depositary Shares | SSaleDisposed | −1,304 | $2.85 | −$3,716.4 | 34,000 | Direct | |
| Aug 28, 2026 | American Depositary Shares | SSaleDisposed | −1,000 | $2.80 | −$2,800 | 33,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2020 | American Depositary Shares | AGrant or awardAcquired | +172 | $0.00 | $0 | 172 | Direct | |
| Apr 19, 2021 | American Depositary Shares | AGrant or awardAcquired | +2,971 | $0.00 | $0 | 3,143 | Direct | |
| Mar 7, 2022 | American Depositary Shares | AGrant or awardAcquired | +1,705 | $0.00 | $0 | 4,848 | Direct | |
| Mar 21, 2023 | American Depositary Shares | AGrant or awardAcquired | +1,714 | $0.00 | $0 | 6,562 | Direct | |
| Mar 18, 2024 | American Depositary Shares | AGrant or awardAcquired | +2,520 | $0.00 | $0 | 9,082 | Direct | |
| Mar 16, 2025 | American Depositary Shares | AGrant or awardAcquired | +3,821 | $0.00 | $0 | 12,903 | Direct | |
| Mar 16, 2026 | American Depositary Shares | AGrant or awardAcquired | +5,172 | $0.00 | $0 | 18,075 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.